Stefano Gambardella

ORCID: 0000-0002-3727-4502
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Parkinson's Disease Mechanisms and Treatments
  • Autophagy in Disease and Therapy
  • Genetic Neurodegenerative Diseases
  • Cystic Fibrosis Research Advances
  • Genomics and Rare Diseases
  • Neurological diseases and metabolism
  • Amyotrophic Lateral Sclerosis Research
  • Multiple Sclerosis Research Studies
  • Cellular transport and secretion
  • RNA Research and Splicing
  • Genetics and Neurodevelopmental Disorders
  • Alzheimer's disease research and treatments
  • Genomic variations and chromosomal abnormalities
  • RNA regulation and disease
  • Neurogenetic and Muscular Disorders Research
  • Neonatal Respiratory Health Research
  • Epigenetics and DNA Methylation
  • Mitochondrial Function and Pathology
  • Hereditary Neurological Disorders
  • Neurogenesis and neuroplasticity mechanisms
  • Cerebrovascular and genetic disorders
  • Nuclear Receptors and Signaling
  • Nerve injury and regeneration
  • Rheumatoid Arthritis Research and Therapies
  • Histone Deacetylase Inhibitors Research

Istituto Neurologico Mediterraneo
2015-2024

University of Urbino
2020-2024

Istituti di Ricovero e Cura a Carattere Scientifico
2016

University of Rome Tor Vergata
2004-2011

Fondazione Roma
2010-2011

Policlinico Tor Vergata
2010

Alliance Bioversity International - CIAT
2010

Istituto di Genetica Molecolare
2005

Alessandro Gialluisi Mafalda Giovanna Reccia Nicola Modugno Teresa Nutile Alessia Lombardi and 95 more Luca Giovanni Di Giovannantonio Sara Pietracupa Daniela Ruggiero Simona Scala Stefano Gambardella Alastair Noyce Rauan Kaiyrzhanov Ben Middlehurst Demis A. Kia Manuela Tan Henry Houlden Huw R. Morris Hélène Plun‐Favreau Peter Holmans John Hardy Daniah Trabzuni John P. Quinn Vivien J. Bubb Kin Y. Mok Kerri J. Kinghorn Kimberley Billingsley Nicholas Wood Patrick A. Lewis Sebastian R. Schreglmann Ruth C. Lovering Lea R’Bibo Claudia Manzoni Mie Rizig Mina Ryten Sebastian Guelfi Valentina Escott‐Price Viorica Chelban Thomas Foltynie Nigel Williams Karen Morrison Carl E Clarke Alexis Brice Alexis Brice Suzanne Lesage Jean‐Christophe Corvol María Martínez Claudia Schulte Kathrin Brockmann Javier Simón‐Sánchez Peter Heutink Patrizia Rizzu Manu Sharma Thomas Gasser Mark Cookson Sara Bandrés‐Ciga Cornelis Blauwendraat David W. Craig Derek P. Narendra Faraz Faghri J. Raphael Gibbs Dena Hernández Kendall Van Keuren‐Jensen Joshua Shulman Hirotaka Iwaki Hampton L. Leonard Mike A. Nalls Laurie Robak José Brás Rita Guerreiro Steven Lubbe Steven Finkbeiner Niccoló E. Mencacci Codrin Lungu Andrew Singleton Sonja W. Scholz Xylena Reed Roy N. Alcalay Ziv Gan‐Or Guy A. Rouleau Lynne Krohn Lynne Krohn Jacobus J. van Hilten Johan Marinus Astrid Adarmes‐Gómez Miquel Aguilar Ignacio Álvarez Victoria Álvarez Francisco Javier Barrero Jesús Alberto Bergareche Yarza Inmaculada Bernal‐Bernal Marta Blázquez Estrada Marta Bonilla‐Toribio Juan A. Botía María Teresa Boungiorno Dolores Buiza‐Rueda Fátima Carrillo Mario Carrión‐Claro Debora Cerdan Jordi Clarimón Yaroslau Compta

Abstract Background Parkinson’s disease (PD) is a neurodegenerative movement disorder affecting 1–5% of the general population for which neither effective cure nor early diagnostic tools are available that could tackle pathology in phase. Here we report multi-stage procedure to identify candidate genes likely involved etiopathogenesis PD. Methods The study includes discovery stage based on analysis whole exome data from 26 dominant late onset PD families, validation performed 1542...

10.1186/s13024-021-00455-2 article EN cc-by Molecular Neurodegeneration 2021-06-21
Eva‐Juliane Vollstedt Susen Schaake Katja Lohmann Shalini Padmanabhan Alexis Brice and 95 more Suzanne Lesage Christelle Tesson Marie Vidailhet Isabel Wurster F. Hentati Anat Mirelman Nir Giladi Karen Marder Cheryl Waters Stanley Fahn Meike Kasten Norbert Brüggemann Max Borsche Tatiana Foroud Eduardo Tolosa Alícia Garrido Grazia Annesi Monica Gagliardi Maria Bozi Leonidas Stefanis Joaquim J. Ferreira Leonor Correia Guedes Micol Avenali Simona Petrucci Lorraine N. Clark E. Yu. Fedotova Natalya Abramycheva Victoria Álvarez Manuel Menéndez‐González S. Jesús Maestre Pilar Gómez‐Garre Pablo Mir Andrea Carmine Belin Caroline Ran Chin‐Hsien Lin Ming‐Che Kuo David Crosiers Zbigniew K. Wszołek Owen A. Ross Joseph Jankovic Kenya Nishioka Manabu Funayama Jordi Clarimón Caroline H. Williams‐Gray Marta Camacho Mario Cornejo‐Olivas Luis Torres-Ramírez Yih‐Ru Wu Guey‐Jen Lee‐Chen Ana Morgadinho Teeratorn Pulkes Pichet Termsarasab Daniela Berg Gregor Kuhlenbäumer Andrea A. Kühn Friederike Borngräber Giuseppe De Michele Anna De Rosa Alexander Zimprich Andreas Puschmann George D. Mellick Jolanta Dorszewska Jonathan Carr Rosangela Ferese Stefano Gambardella Bruce A. Chase Katerina Markopoulou Wataru Satake Tatsushi Toda Malco Rossi Marcelo Merello Timothy Lynch Diana A. Olszewska Shen‐Yang Lim Azlina Ahmad‐Annuar Ai Huey Tan Bashayer Al‐Mubarak Haşmet Hanağası Dariusz Koziorowski Sibel Ertan Gençer Genç Patrícia de Carvalho Aguiar Melinda Barkhuizen Márcia Mattos Gonçalves Pimentel Rachel Saunders‐Pullman Bart van de Warrenburg Susan Bressman Mathias Toft Silke Appel‐Cresswell Anthony E. Lang Matěj Škorvánek Agnita J.W. Boon Rejko Krüger Esther Sammler Vítor Tumas

Abstract Background As gene‐targeted therapies are increasingly being developed for Parkinson's disease (PD), identifying and characterizing carriers of specific genetic pathogenic variants is imperative. Only a small fraction the estimated number subjects with monogenic PD worldwide currently represented in literature availability clinical data trial‐ready cohorts limited. Objective The objectives to (1) establish an international cohort affected unaffected individuals PD‐linked variants;...

10.1002/mds.29288 article EN cc-by Movement Disorders 2023-01-24

MicroRNAs are highly conserved, noncoding RNAs involved in post-transcriptional gene silencing. They have been shown to participate a wide range of biological processes, including myogenesis and muscle regeneration. The goal this study is test the hypothesis that myo-miRs (myo = + miR miRNA) expression altered from patients affected by myotonic dystrophy type 1 (DM1), most frequently inherited neuromuscular disease adults. In order gain better insights about role miRNAs DM1 pathogenesis, we...

10.1186/1479-5876-8-48 article EN cc-by Journal of Translational Medicine 2010-05-20

Angiotensin-converting enzyme 2 (ACE2) has been recognized as the entry receptor of novel severe acute respiratory syndrome coronavirus (SARS-Cov-2). Structural and sequence variants in ACE2 gene may affect its expression different tissues determine a differential response to SARS-Cov-2 infection COVID-19-related phenotype. The present study investigated genetic variability terms single nucleotide (SNVs), copy number variations (CNVs), quantitative loci (eQTLs) cohort 268 individuals...

10.3390/genes11070741 article EN Genes 2020-07-03

To assess specific etiologies of acute recurrent pancreatitis at a single Italian pediatric cystic fibrosis (CF) center.We studied, retrospectively, 78 young patients (39 female subjects; mean age diagnosis, 8.8 ± 5.1 years) affected by episodes pancreatitis, remained etiologically undiagnosed first-level assessment. All were submitted to endoscopic retrograde cholangiopancreatography exclude biliopancreatic malformations and tested for CF sweat chloride test. Most also studied the research...

10.1097/mpa.0b013e318214fe42 article EN Pancreas 2011-03-30

Given the heterogeneous nature of frontotemporal dementia (FTD), sensitive biomarkers are greatly needed for accurate diagnosis this neurodegenerative disorder. Circulating miRNAs have been reported as promising disorders and processes affecting central nervous system, especially in aging. The objective study was to evaluate if some circulating linked with apoptosis (miR-29b-3p, miR-34a-5p, miR-16-5p, miR-17-5p, miR-107, miR-19b-3p, let-7b-5p, miR-26b-5p, 127-3p) were able distinguish...

10.3233/jad-180364 article EN Journal of Alzheimer s Disease 2018-07-21

Background . Parkinson’s disease (PD) is mostly characterized by alpha-synuclein ( SNCA ) aggregation and loss of nigrostriatal dopamine-containing neurons. In this study a novel multiplication described in two siblings affected severe parkinsonism featuring early onset dyskinesia, psychiatric symptoms, cognitive deterioration. Methods dosage was performed using High-Density Comparative Genomic Hybridization Array (CGH-Array), Multiple Ligation Dependent Probe Amplification (MLPA),...

10.1155/2015/546462 article EN cc-by Parkinson s Disease 2015-01-01

Protein clearing pathways named autophagy (ATG) and ubiquitin proteasome (UP) control homeostasis within eukaryotic cells, while their dysfunction produces neurodegeneration. These are viewed as distinct biochemical cascades occurring specific cytosolic compartments owing pathway-specific enzymatic activity. Recent data strongly challenged the concept of two morphologically functionally segregated compartments. In fact, preliminary evidence suggests convergence these to form a novel...

10.3389/fnana.2016.00078 article EN cc-by Frontiers in Neuroanatomy 2016-07-21

Glioblastoma (GBM) cells feature mitochondrial alterations, which are documented and quantified in the present study, by using ultrastructural morphometry. Mitochondrial impairment, roughly occurs half of organelles, is shown to be related mTOR overexpression autophagy suppression. The novelty study consists detailing an mTOR-dependent mitophagy occlusion, along with suppression fission. These phenomena contribute explain increase altered mitochondria reported here. Administration inhibitor...

10.3390/ijms22105379 article EN International Journal of Molecular Sciences 2021-05-20

Treacher Collins syndrome (TCS) is one of the most severe autosomal dominant congenital disorders craniofacial development and shows variable phenotypic expression. TCS extremely rare, occurring with an incidence 1 in 50.000 live births. The distinguishing characteristics are represented by down slanting palpebral fissures, coloboma eyelid, micrognathia, microtia other deformity ears, hypoplastic zygomatic arches, macrostomia. Conductive hearing loss cleft palate often present. results from...

10.1186/1471-2350-12-125 article EN cc-by BMC Medical Genetics 2011-09-27

Methamphetamine (Meth) produces a variety of epigenetic effects in the brain, which are seminal to establish long-lasting alterations neuronal activity. However, most changes were described by measuring rough amount either histone acetylation and methylation or direct DNA methylation, without focusing on specific sequence. This point is key comprehend Meth-induced phenotypic changes, brain plasticity, addiction neurodegeneration. In this research paper we analyze persistence striatal...

10.1016/j.brainres.2019.05.035 article EN cc-by-nc-nd Brain Research 2019-05-28

Exposure to loud noise is a major environmental threat public health. Loud exposure, apart from affecting the inner ear, deleterious for cardiovascular, endocrine and nervous systems it associated with neuropsychiatric disorders. In this study we investigated DNA, neurotransmitters immune-histochemical alterations induced by exposure in three brain areas (cerebellum, hippocampus, striatum) of Wistar rats. Rats were exposed (100 dBA) 12 h. The effects on DNA integrity all evaluated using...

10.3389/fnana.2017.00049 article EN cc-by Frontiers in Neuroanatomy 2017-06-26
Coming Soon ...